Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma
Veronica Mollica, Matteo Santoni, Marc Matrana, Umberto Basso, Ugo De Giorgi, Alessandro Rizzo, Marco Maruzzo, Andrea Marchetti, Matteo Rosellini, Sara Bleve, Diana Maslov, Karine Tawagi, Ernest Philon, Zoë Blake, Francesco Massari
Topics & Concepts
MedicineNivolumabIpilimumabInternal medicineCohortRenal cell carcinomaConcomitantRetrospective cohort studyOncologyImmunotherapyCancerRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis